Amlodipine is a dihydropyridine calcium antagonist with a long duration of action, used for the treatment of hypertension and angina pectoris.

Hypertension: Amlodipine is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
Stable Angina: Amlodipine is indicated for the treatment of stable angina. Amlodipine may be used alone or in combination with other antianginal agents.
Vasospastic Angina: Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy or in combination with other antianginal drugs.

The usual initial antihypertensive oral dose is 5 mg once daily, with a maximum dose of 10 mg once daily.
Elderly individuals or patients with hepatic insufficiency may be started on 2.5 mg once daily, and this dose may be used when adding Amlodipine to other antihypertensive therapy.
Dosage should be adjusted according to each patient’s needs. The recommended dose for stable or vasospastic angina is 5-10 mg, with the lower dose suggested for the elderly and in patients with hepatic insufficiency.

Amlodipine is contraindicated in patients with known hypersensitivity to Amlodipine.

Pregnancy: Amlodipine should not be administered during pregnancy or to women of childbearing potential unless effective contraception is used.
Lactation: Amlodipine should not be used by nursing mothers. If its use is considered necessary, breastfeeding should be stopped.

General: Since the vasodilation induced by Amlodipine is gradual in onset, acute hypotension has rarely been reported after oral administration. Nonetheless, caution should be exercised when administering Amlodipine, as with any other peripheral vasodilator, particularly in patients with severe aortic stenosis.
Use in Patients with Congestive Heart Failure: Although hemodynamic studies and a controlled trial in class II-III heart failure patients have shown that Amlodipine did not lead to clinical deterioration as measured by exercise tolerance, left ventricular ejection fraction, and clinical symptomatology, all calcium channel blockers should be used with caution in patients with heart failure.
Beta-Blocker Withdrawal: Amlodipine does not provide protection against the dangers of abrupt beta-blocker withdrawal. Any such withdrawal should involve a gradual reduction in the dose of the beta-blocker.
Hepatic Failure: Since Amlodipine is extensively metabolized by the liver, caution should be exercised when administering it to patients with hepatic impairment.

No significant drug interactions have been reported.

Peripheral edema may occasionally be severe but is fully reversible.
As with other calcium antagonist drugs, peripheral edema and skin erythema occur in 5-10% of patients, while facial flushing occurs in 2-5%.
Complaints of fatigue were also reported more frequently than in placebo-treated patients.
There is evidence that these effects are more common in patients treated with doses greater than 10 mg daily.

In humans, experience with intentional overdose of Amlodipine is limited. If massive overdose occurs:
Active cardiac and respiratory monitoring should be instituted.
Frequent blood pressure measurements are essential

Store in a cool and dry place below 30ºC. Protect from light and moisture.
Medicine: Keep out of reach of children.
